Tangible book value per share is calculated as the total tangible equity divided by Shares Outstanding (EOP). Total tangible equity is calculated as the Total Stockholders Equity minus Preferred Stock minus Intangible Assets. Shanghai INT Medical Instruments Co's tangible book value per share for the quarter that ended in Dec. 2023 was HK$9.13.
Since intangibles such as goodwill cannot be sold when the company liquidates, tangible book value per share is considered more accurate in reflecting how much shareholders will receive when the company liquidates.
Shanghai INT Medical Instruments Co Tangible Book per Share Historical Data
The historical data trend for Shanghai INT Medical Instruments Co's Tangible Book per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Shanghai INT Medical Instruments Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai INT Medical Instruments Co Price-to-Tangible-Book Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai INT Medical Instruments Co's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Shanghai INT Medical Instruments Co's Price-to-Tangible-Book falls into.
Shanghai INT Medical Instruments Co Tangible Book per Share Calculation
Shanghai INT Medical Instruments Co's Tangible Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Theoretically it is what the shareholders will receive if the company is liquidated. Total equity is a balance sheet item and equal to total assets less total liabilities of the company. Since intangibles such as goodwill cannot be sold when the company liquidates, tangible book value per share is considered more accurate in reflecting how much shareholders will receive when the company liquidates.
Shanghai INT Medical Instruments Co (HKSE:01501) Tangible Book per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Shanghai INT Medical Instruments Co Tangible Book per Share Related Terms
Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's Tangible Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Shanghai INT Medical Instruments Co (HKSE:01501) Business Description
Shanghai INT Medical Instruments Co Ltd formerly Shanghai Kindly Medical Instruments Co Ltd is a manufacturer of cardiovascular interventional devices, which are mainly used in cardiovascular surgeries, and in particular, PCI procedures in China. It is engaged in the sales, manufacture, research, and development of cardiovascular interventional medical devices as well as related accessories and molds. It is also engaged in the research and development of other interventional and implantable medical devices, such as neurological interventional medical devices and endocardia implantable medical devices, among others. Geographically, it has operations in Mainland China, Europe, the United States, and Other countries.
Shanghai INT Medical Instruments Co (HKSE:01501) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01501 has been successfully added to your 